as 07-30-2025 9:39am EST
Founded: | 2002 | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 66.0K |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.71 | EPS Growth: | N/A |
52 Week Low/High: | $1.82 - $3.09 | Next Earning Date: | 08-15-2025 |
Revenue: | $2,000,000 | Revenue Growth: | 196.74% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ORMP Breaking Stock News: Dive into ORMP Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Leasing Life
2 months ago
Offshore Technology
2 months ago
AFP
2 months ago
Footwear News
2 months ago
Business Wire
2 months ago
Investopedia
2 months ago
GlobeNewswire
2 months ago
The information presented on this page, "ORMP Oramed Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.